Cite
MLA Citation
Daniel Meijles et al.. “228 Braf inhibitors, sb590885 and dabrafenib, enhance erk1/2 signalling in cardiomyocytes and promote cardiac hypertrophy.” Heart, vol. 103, n.d., pp. A146–A147. http://access.bl.uk/ark:/81055/vdc_100144720468.0x000015